Rare Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You were 18 years old or older when you were diagnosed with cancer
- You have been diagnosed with a tumour that had special molecular (genetic) testing done, which found unusual or rare changes in the tumour's genetic makeup
- You have access to the paperwork or reports from that genetic testing (which may have been done using methods such as NGS, PCR, IHC, FISH, or a liquid biopsy test) (confirm with trial site if unsure which tests you had)
- You are a Canadian resident who received cancer care follow-up in Canada, or who is currently receiving or planning to receive cancer care follow-up in Canada at the time of joining the trial
Who may not be able to join:
- If the patient has passed away and previously declined to join this study while they were alive, they cannot be enrolled
- Anyone who is not able to give their own informed consent to participate in the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Geoffrey Liu, MD, MSc, Princess Margaret Cancer Centre
Phone: 416-946-4501
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Composite of Progression Free Survival [PFS] or Overall Survival [OS]
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.